Medically reviewed by Christine L. Larsen, MD Myopic macular degeneration (MMD), or pathological myopia, occurs when high ...

The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.

Five years from the start of the COVID-19 pandemic, numerous academic studies have shown how the novel coronavirus affects ocular health.

Bryan Wolynski, a board-certified optometrist, discusses what patients should know before their first appointment for ...

In today’s digitally driven world, the average person spends a significant portion of their day looking at screens—phones, ...

As the pollen count continues to rise, a pharmacist has shared his tips on how to tackle eye health issues when pollen ...

Aldeyra Therapeutics shares fell 73% to $1.42 in the regular session after it reported a Food and Drug Administration complete response letter for reproxalap for treatment of dry eye disease. The ...

The FDA issued a complete response letter for the resubmission of the reproxalap new drug application for the treatment of ...

The Company expects to have topline data from 2 trials assessing the effect of reproxalap on dry eye disease symptoms available in the second quarter of 2025.

As we approach World Health Day (Monday 7 April), it’s an ideal opportunity to turn inwards and check on our own health and ...

The topical ocular drug is an investigational new drug candidate that requires more well-controlled studies to establish ...

The company stated that the FDA noted at least one additional adequate and well controlled study to demonstrate a positive ...